Retina World Congress
By Rishi Singh, MD
Rishi Singh, MD
• staff physician, associate professor of ophthalmology, Cleveland Clinic
• financial disclosure: president, Retina World Congress
• drrishisingh@retinaworldcongress.org
Innovations in retina occur globally. Drugs, devices, and techniques are pioneered across the world. Although regional societies can serve as channels of communication among doctors in particular regions, these independent organizations lack a forum where surgeons can share surgical techniques and discuss tactics for managing complex cases.
Enter the Retina World Congress (RWC), a sort-of United Nations of retina. It’s a first-of-its-kind meeting at which international groups will work collaboratively to create its agenda. The RWC provides an open forum for international participants to attend and learn from an all-star panel of speakers. Attendees will have the opportunity to listen to the surgical, medical, and imaging strategies employed by their international peers, and they are eligible for continuing medical education credit. The goal is global retina collaboration, and attendees will have the opportunity to participate in collaborative research opportunities and present unique data.
The RWC is not a membership organization, and attendees will have open access to the meeting. This meeting is a unique opportunity for retina specialists to grasp the scope and shape of retina’s international evolution.
So far, 22 international retina societies have secured their positions at the inaugural RWC, to be held February 23 to 26, 2017, in Fort Lauderdale, Fla. To register for the meeting, visit www.retinaworldcongress.org.
Rishi Singh, MD
• staff physician, associate professor of ophthalmology, Cleveland Clinic
• financial disclosure: president, Retina World Congress
• drrishisingh@retinaworldcongress.org
Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal i…
GenSight Biologics announced that a phase 3 study of GS010 (rAAV2/2-ND4) in patients with Leber hereditary optic neuropathy (LHON) failed to meet its primary endpoint, with sh…
A retrospective chart review was performed for 71 eyes of 67 patients with neovascular age-related macular degeneration (AMD) treated with intravitreal anti-vascular endotheli…
Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087
Phone: 484-581-1800
Fax: 484-581-1818
Michael Jones
Senior Editor
484-581-1821
mjones@bmctoday.com
Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com
New Retina MD delivers cutting-edge content to retina specialists in their first 15 years of practice. Each issue provides fresh insight from younger physicians plus established mentors on clinical and nonclinical issues affecting ophthalmologists in the earlier stages of their careers. NRMD features surgical pearls, clinical research endeavors, practice management, medical reimbursement and policy, continuing educational requirements, financial planning, innovations, and more.
We use cookies to offer a better user experience and to analyze site traffic. To comply with the European General Data Protection Regulation (GDPR), we are implementing a cookie consent manager to provide residents of the EU/EEA with the ability to customize their cookies. Until this is available, your continued use of this site will be deemed as consent to use of cookies.
Continue »